| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | spectrin binding | 1.89e-06 | 34 | 122 | 5 | GO:0030507 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.96e-06 | 20 | 122 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 IPO5 RANBP2 RGPD8 GBP1 GBP2 GBP3 RGPD3 FGD6 ARHGEF6 RGPD5 SOS1 SOS2 | 1.38e-05 | 507 | 122 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 IPO5 RANBP2 RGPD8 GBP1 GBP2 GBP3 RGPD3 FGD6 ARHGEF6 RGPD5 SOS1 SOS2 | 1.38e-05 | 507 | 122 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | G protein activity | 3.02e-05 | 59 | 122 | 5 | GO:0003925 | |
| GeneOntologyMolecularFunction | myosin tail binding | 3.70e-05 | 2 | 122 | 2 | GO:0032029 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 4.70e-05 | 12 | 122 | 3 | GO:0004382 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 6.72e-05 | 36 | 122 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 2.35e-04 | 20 | 122 | 3 | GO:0017110 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.46e-04 | 50 | 122 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 3.08e-04 | 53 | 122 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 3.56e-04 | 55 | 122 | 4 | GO:0051879 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CTNNAL1 MAP7D3 ATCAY CAPN6 GBP1 GBP2 GAS7 GBP3 PSMD10 LCP1 USH1C HDGFL3 CLIP4 SPTBN5 STAU2 USH2A MYBPC2 | 3.73e-04 | 1099 | 122 | 17 | GO:0008092 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.24e-09 | 20 | 120 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.34e-07 | 9 | 120 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.23e-07 | 10 | 120 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 7.48e-07 | 13 | 120 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 7.65e-07 | 4 | 120 | 3 | GO:0140973 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.04e-06 | 14 | 120 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 3.79e-06 | 6 | 120 | 3 | GO:0140971 | |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 1.05e-05 | 8 | 120 | 3 | GO:0140970 | |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 1.57e-05 | 9 | 120 | 3 | GO:0051715 | |
| GeneOntologyBiologicalProcess | positive regulation of pyroptotic inflammatory response | 1.57e-05 | 9 | 120 | 3 | GO:0140639 | |
| GeneOntologyBiologicalProcess | cytolysis | 4.07e-05 | 12 | 120 | 3 | GO:0019835 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 6.90e-05 | 38 | 120 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 1.02e-04 | 16 | 120 | 3 | GO:0006002 | |
| GeneOntologyBiologicalProcess | pyroptotic inflammatory response | 1.03e-04 | 42 | 120 | 4 | GO:0070269 | |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 2.04e-04 | 20 | 120 | 3 | GO:0044406 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 2.75e-04 | 54 | 120 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | RNA localization | 2.82e-04 | 217 | 120 | 7 | GO:0006403 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 7.10e-08 | 8 | 120 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.11e-07 | 10 | 120 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 9.89e-07 | 14 | 120 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.97e-06 | 18 | 120 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | host cell part | 3.64e-06 | 6 | 120 | 3 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 3.64e-06 | 6 | 120 | 3 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 3.64e-06 | 6 | 120 | 3 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 3.64e-06 | 6 | 120 | 3 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 3.64e-06 | 6 | 120 | 3 | GO:0020005 | |
| GeneOntologyCellularComponent | host intracellular region | 3.64e-06 | 6 | 120 | 3 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 3.64e-06 | 6 | 120 | 3 | GO:0030430 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.66e-06 | 20 | 120 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 5.73e-06 | 21 | 120 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.01e-05 | 8 | 120 | 3 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.51e-05 | 9 | 120 | 3 | GO:0044217 | |
| GeneOntologyCellularComponent | nuclear pore | 2.56e-05 | 101 | 120 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | host cellular component | 7.98e-05 | 15 | 120 | 3 | GO:0018995 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 4.83e-04 | 6 | 120 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 4.83e-04 | 6 | 120 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium | 6.70e-04 | 69 | 120 | 4 | GO:0032420 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 8.95e-04 | 8 | 120 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | nuclear membrane | 9.25e-04 | 349 | 120 | 8 | GO:0031965 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ANKRD13D RGPD4 RANBP2 RGPD8 ATCAY CAPN6 GBP1 GBP2 GBP3 LCP1 YWHAB TF RGPD3 RAB2A | 9.41e-04 | 934 | 120 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | stereocilium bundle | 1.11e-03 | 79 | 120 | 4 | GO:0032421 | |
| GeneOntologyCellularComponent | inclusion body | 1.80e-03 | 90 | 120 | 4 | GO:0016234 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.76e-06 | 16 | 90 | 4 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 2.16e-05 | 26 | 90 | 4 | MP:0012058 | |
| MousePheno | decreased tumor latency | 3.87e-05 | 30 | 90 | 4 | MP:0010308 | |
| MousePheno | increased susceptibility to parasitic infection induced morbidity/mortality | 4.10e-05 | 11 | 90 | 3 | MP:0010750 | |
| MousePheno | failure of blastocyst formation | 4.43e-05 | 31 | 90 | 4 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 6.43e-05 | 34 | 90 | 4 | MP:0010307 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 6.46e-05 | 107 | 90 | 6 | MP:0003694 | |
| MousePheno | abnormal blastocyst hatching | 8.76e-05 | 113 | 90 | 6 | MP:0003693 | |
| MousePheno | abnormal blastocyst formation | 1.11e-04 | 39 | 90 | 4 | MP:0012128 | |
| MousePheno | abnormal rod electrophysiology | 1.17e-04 | 119 | 90 | 6 | MP:0004021 | |
| MousePheno | increased heart rate variability | 1.36e-04 | 41 | 90 | 4 | MP:0003928 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.94e-04 | 141 | 90 | 6 | MP:0004499 | |
| Domain | Ran_BP1 | 7.07e-09 | 12 | 118 | 5 | PF00638 | |
| Domain | RANBD1 | 7.07e-09 | 12 | 118 | 5 | PS50196 | |
| Domain | RanBD | 1.14e-08 | 13 | 118 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 1.14e-08 | 13 | 118 | 5 | IPR000156 | |
| Domain | Grip | 4.83e-07 | 11 | 118 | 4 | SM00755 | |
| Domain | GRIP | 4.83e-07 | 11 | 118 | 4 | PF01465 | |
| Domain | GRIP_dom | 7.21e-07 | 12 | 118 | 4 | IPR000237 | |
| Domain | GRIP | 7.21e-07 | 12 | 118 | 4 | PS50913 | |
| Domain | Rab_bind | 8.45e-06 | 7 | 118 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 8.45e-06 | 7 | 118 | 3 | IPR032023 | |
| Domain | GBP_C | 2.86e-05 | 10 | 118 | 3 | PF02841 | |
| Domain | - | 2.86e-05 | 10 | 118 | 3 | 1.10.220.60 | |
| Domain | G_GB1_RHD3_dom | 3.91e-05 | 11 | 118 | 3 | IPR030386 | |
| Domain | Guanylate-bd_N | 3.91e-05 | 11 | 118 | 3 | IPR015894 | |
| Domain | Guanylate-bd_C | 3.91e-05 | 11 | 118 | 3 | IPR003191 | |
| Domain | GBP | 3.91e-05 | 11 | 118 | 3 | PF02263 | |
| Domain | G_GB1_RHD3 | 3.91e-05 | 11 | 118 | 3 | PS51715 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 SPTBN5 RGPD3 FGD6 ARHGEF6 RGPD5 SOS1 SOS2 | 3.73e-04 | 426 | 118 | 10 | IPR011993 |
| Domain | - | 8.47e-04 | 391 | 118 | 9 | 2.30.29.30 | |
| Domain | RhoGEF | 9.03e-04 | 68 | 118 | 4 | SM00325 | |
| Domain | RhoGEF | 1.01e-03 | 70 | 118 | 4 | PF00621 | |
| Domain | DH_2 | 1.01e-03 | 70 | 118 | 4 | PS50010 | |
| Domain | - | 1.06e-03 | 71 | 118 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.06e-03 | 71 | 118 | 4 | IPR000219 | |
| Domain | VIT | 1.08e-03 | 8 | 118 | 2 | PF08487 | |
| Domain | VIT | 1.08e-03 | 8 | 118 | 2 | SM00609 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 4.06e-06 | 18 | 88 | 4 | MM1549 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.19e-05 | 82 | 88 | 6 | MM15394 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.30e-05 | 49 | 88 | 5 | MM14837 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.09e-04 | 40 | 88 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.20e-04 | 41 | 88 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.32e-04 | 42 | 88 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.45e-04 | 43 | 88 | 4 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.98e-04 | 86 | 88 | 5 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.06e-04 | 47 | 88 | 4 | MM14939 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.62e-04 | 50 | 88 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.83e-04 | 51 | 88 | 4 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.79e-04 | 55 | 88 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.65e-04 | 58 | 88 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.65e-04 | 58 | 88 | 4 | MM14736 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 4.97e-04 | 59 | 88 | 4 | M39750 | |
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 21205196 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 18949001 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 25187515 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 9037092 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 8603673 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 5.00e-09 | 7 | 122 | 4 | 15710750 | |
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 26632511 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 24403063 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 5.00e-09 | 7 | 122 | 4 | 11353387 | |
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 30944974 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 38838144 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 5.00e-09 | 7 | 122 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 5.00e-09 | 7 | 122 | 4 | 17372272 | |
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 38657106 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 12191015 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 22821000 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 9.98e-09 | 8 | 122 | 4 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 9.98e-09 | 8 | 122 | 4 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 9.98e-09 | 8 | 122 | 4 | 28745977 | |
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 9.98e-09 | 8 | 122 | 4 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.79e-08 | 9 | 122 | 4 | 18394993 | |
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 11553612 | ||
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 10601307 | ||
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 9733766 | ||
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 28100513 | ||
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 28877029 | ||
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.98e-08 | 10 | 122 | 4 | 8857542 | |
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.98e-08 | 10 | 122 | 4 | 16332688 | |
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 21859863 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 30062052 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 26416908 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 32354743 | ||
| Pubmed | GTPase properties of the interferon-induced human guanylate-binding protein 2. | 4.21e-08 | 3 | 122 | 3 | 8706832 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 32620042 | ||
| Pubmed | [Guanylate-binding protein 2 regulates the maturation of mouse dendritic cells induced by β-glucan]. | 4.21e-08 | 3 | 122 | 3 | 29089068 | |
| Pubmed | Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. | 4.21e-08 | 3 | 122 | 3 | 23248289 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 1715024 | ||
| Pubmed | Two families of GTPases dominate the complex cellular response to IFN-gamma. | 4.21e-08 | 3 | 122 | 3 | 9862701 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 11726669 | ||
| Pubmed | GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. | 4.21e-08 | 3 | 122 | 3 | 38636926 | |
| Pubmed | Domain motions, dimerization, and membrane interactions of the murine guanylate binding protein 2. | 4.21e-08 | 3 | 122 | 3 | 36639389 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 16914101 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 22730319 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 15717119 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 35383115 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 20950129 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 4.67e-08 | 11 | 122 | 4 | 35771867 | |
| Pubmed | 4.67e-08 | 11 | 122 | 4 | 17069463 | ||
| Pubmed | 4.67e-08 | 11 | 122 | 4 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.01e-07 | 13 | 122 | 4 | 31427429 | |
| Pubmed | Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. | 1.68e-07 | 4 | 122 | 3 | 7823961 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 36609599 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 10386861 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 38404575 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 9480752 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 8917111 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 39337476 | ||
| Pubmed | 1.91e-07 | 15 | 122 | 4 | 14697343 | ||
| Pubmed | TCR Affinity Biases Th Cell Differentiation by Regulating CD25, Eef1e1, and Gbp2. | 4.19e-07 | 5 | 122 | 3 | 30858199 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 12396730 | ||
| Pubmed | Unique features of different members of the human guanylate-binding protein family. | 4.19e-07 | 5 | 122 | 3 | 17266443 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 21151871 | ||
| Pubmed | Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection. | 4.19e-07 | 5 | 122 | 3 | 31964735 | |
| Pubmed | Murine GBP-2: a new IFN-gamma-induced member of the GBP family of GTPases isolated from macrophages. | 4.19e-07 | 5 | 122 | 3 | 9858320 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 17293456 | ||
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 21757726 | ||
| Pubmed | 1.00e-06 | 22 | 122 | 4 | 27717094 | ||
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 20505078 | ||
| Pubmed | TRIF signaling is required for caspase-11-dependent immune responses and lethality in sepsis. | 1.46e-06 | 7 | 122 | 3 | 30587103 | |
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 21502320 | ||
| Pubmed | 1.78e-06 | 103 | 122 | 6 | 21706016 | ||
| Pubmed | In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. | 2.33e-06 | 8 | 122 | 3 | 16689661 | |
| Pubmed | RGPD4 RANBP2 RGPD8 ATG2B TNRC6B ANAPC1 RGPD3 ZKSCAN3 XRN1 CEP131 | 2.35e-06 | 418 | 122 | 10 | 34709266 | |
| Pubmed | Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. | 3.48e-06 | 9 | 122 | 3 | 24739961 | |
| Pubmed | Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. | 3.48e-06 | 9 | 122 | 3 | 33479228 | |
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 4.96e-06 | 10 | 122 | 3 | 28334111 | |
| Pubmed | SEL1L DCAF1 RANBP2 CHORDC1 YWHAB NDUFS8 PARP4 PSIP1 ANAPC1 PLOD1 | 5.17e-06 | 457 | 122 | 10 | 22190034 | |
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 6.81e-06 | 11 | 122 | 3 | 24715728 | |
| Pubmed | IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes. | 6.81e-06 | 11 | 122 | 3 | 27693356 | |
| Pubmed | Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. | 6.81e-06 | 11 | 122 | 3 | 18025219 | |
| Pubmed | RGPD4 RANBP2 MIA3 UBAP2 RGPD8 TNRC6B FYCO1 YWHAB ANAPC1 ZC3H4 RGPD3 DCHS1 CEP131 RAB2A | 7.60e-06 | 963 | 122 | 14 | 28671696 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.65e-06 | 202 | 122 | 7 | 33005030 | |
| Pubmed | 9.05e-06 | 12 | 122 | 3 | 35906252 | ||
| Pubmed | 9.05e-06 | 12 | 122 | 3 | 29459437 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 9.70e-06 | 38 | 122 | 4 | 12791264 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | THOC1 RANBP2 UBAP2 MAP7D3 TNRC6B PFKL PARP4 ANAPC1 ZC3H4 STAU2 XRN1 PLOD1 | 9.74e-06 | 724 | 122 | 12 | 36232890 |
| Pubmed | Molecular cloning and characterization of a novel human Rab ( Rab2B) gene. | 1.22e-05 | 2 | 122 | 2 | 12376746 | |
| Pubmed | Dimerization and its role in GMP formation by human guanylate binding proteins. | 1.22e-05 | 2 | 122 | 2 | 20923658 | |
| Pubmed | The interferon-inducible GBP1 gene: structure and mapping to human chromosome 1. | 1.22e-05 | 2 | 122 | 2 | 7518790 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15169895 | ||
| Pubmed | A homologue of the Drosophila Son of sevenless gene maps to mouse chromosome 17. | 1.22e-05 | 2 | 122 | 2 | 8307589 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25973715 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 36460216 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28063257 | ||
| Interaction | RGPD4 interactions | 1.67e-07 | 22 | 120 | 5 | int:RGPD4 | |
| Interaction | RGPD1 interactions | 4.46e-07 | 49 | 120 | 6 | int:RGPD1 | |
| Interaction | RGPD2 interactions | 5.00e-07 | 27 | 120 | 5 | int:RGPD2 | |
| Interaction | RGPD8 interactions | 5.23e-06 | 74 | 120 | 6 | int:RGPD8 | |
| Interaction | RGPD3 interactions | 8.65e-06 | 47 | 120 | 5 | int:RGPD3 | |
| Interaction | RGPD5 interactions | 2.35e-05 | 96 | 120 | 6 | int:RGPD5 | |
| Interaction | GBP3 interactions | 2.40e-05 | 10 | 120 | 3 | int:GBP3 | |
| Interaction | CEP120 interactions | 4.13e-05 | 106 | 120 | 6 | int:CEP120 | |
| Interaction | CDKL5 interactions | 5.91e-05 | 113 | 120 | 6 | int:CDKL5 | |
| Interaction | CEP162 interactions | 6.66e-05 | 168 | 120 | 7 | int:CEP162 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 4.82e-05 | 147 | 122 | 5 | chr15q15 | |
| Cytoband | 1p22.2 | 5.71e-05 | 28 | 122 | 3 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 5.34e-04 | 59 | 122 | 3 | chr2q13 | |
| Cytoband | 2q13 | 8.09e-04 | 68 | 122 | 3 | 2q13 | |
| Cytoband | 15q15.2 | 8.20e-04 | 16 | 122 | 2 | 15q15.2 | |
| Cytoband | 2q12.3 | 9.28e-04 | 17 | 122 | 2 | 2q12.3 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.97e-04 | 115 | 84 | 5 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.51e-04 | 66 | 84 | 4 | 722 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.54e-05 | 33 | 120 | 4 | MM477 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | RGPD4 DCAF1 RANBP2 TTC41P RGPD8 GBP1 GBP2 GBP3 FYCO1 CHORDC1 ARID3B CD3E PRCC RGPD3 CREB3L3 RAB2A FGD6 ARHGEF6 | 2.06e-05 | 1277 | 120 | 18 | MM1032 |
| Coexpression | MARZEC_IL2_SIGNALING_DN | 2.20e-05 | 36 | 120 | 4 | M13276 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 3.77e-05 | 199 | 120 | 7 | M7553 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 4.49e-05 | 43 | 120 | 4 | MM3857 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RANBP2 ZBTB38 MAP7D3 KAT6A TNRC6B GBP2 GBP3 LCP1 YWHAB PDCD4 RFTN1 CD3E PSIP1 VWA5A XRN1 AKAP10 USP15 ARHGEF6 SOS1 | 4.76e-05 | 1492 | 120 | 19 | M40023 |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.52e-07 | 170 | 122 | 7 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.21e-06 | 197 | 122 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.30e-06 | 199 | 122 | 7 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-06 | 169 | 122 | 6 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.13e-06 | 176 | 122 | 6 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 184 | 122 | 6 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.33e-05 | 188 | 122 | 6 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.37e-05 | 189 | 122 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Severe-Treg|World / Disease group and Cell class | 1.45e-05 | 191 | 122 | 6 | 0a80b8c317e8da4d4722cfd13cdabc32b58021eb | |
| ToppCell | ILEUM-non-inflamed-(1)_Tregs|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.45e-05 | 191 | 122 | 6 | e065d16a1f88c91dec576d248a318534ceab1cb2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 122 | 6 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-05 | 193 | 122 | 6 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 1.63e-05 | 195 | 122 | 6 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-05 | 196 | 122 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 1.78e-05 | 198 | 122 | 6 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 1.78e-05 | 198 | 122 | 6 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 1.78e-05 | 198 | 122 | 6 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | Endothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4) | 2.17e-05 | 122 | 122 | 5 | 2cb8bb63c69aed4d4504b9d97219b8707666f950 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 61 | 122 | 4 | 5e855b5462f42b7a1d0bbd518cc11072342ce0cc | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 61 | 122 | 4 | 2fc13475581431f82e0b5ef42e18cd29c9787666 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-05 | 134 | 122 | 5 | 932b7dd5781b730dcd2ffe43f6e142e3f8630f67 | |
| ToppCell | severe_COVID-19-CD8+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 7.03e-05 | 156 | 122 | 5 | 47aa46cdf5af9834f4b890ac6ce5e8d548ee98db | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.92e-05 | 160 | 122 | 5 | 9f1fec2cf565193c73cc3c8a4f0476e57478e3b8 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.40e-05 | 162 | 122 | 5 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.40e-05 | 162 | 122 | 5 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.64e-05 | 163 | 122 | 5 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 9.16e-05 | 165 | 122 | 5 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 9.16e-05 | 165 | 122 | 5 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.96e-05 | 168 | 122 | 5 | 2781dd6b369427a94c5059b44b4c8f023f5f2988 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 169 | 122 | 5 | a34aff9257ae9746226ee7af595c4678a4b0c896 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 171 | 122 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 171 | 122 | 5 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 171 | 122 | 5 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-04 | 172 | 122 | 5 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 173 | 122 | 5 | b9dc42d629d13e63aada5ae49ba0cbb0952c5fe9 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 174 | 122 | 5 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | Int-URO-Lymphocyte-T_NK-MAIT|Int-URO / Disease, Lineage and Cell Type | 1.17e-04 | 174 | 122 | 5 | 5227ed29f5f0d3e0aaa7f3cfd362f96d3e2660f7 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 176 | 122 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | (1)_T_regulatory|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.27e-04 | 177 | 122 | 5 | 5cda56b10df1ee8971ce8470d52062e01b703a4e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 122 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 178 | 122 | 5 | f52f837e948deb6a2d031325f49891bca8d375da | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.34e-04 | 179 | 122 | 5 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 179 | 122 | 5 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 179 | 122 | 5 | 61dbfc1b9b0344c06a68142c181cd62993556a67 | |
| ToppCell | Monocytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-04 | 181 | 122 | 5 | d8b98c3d9bef026a0a35948219027f27718ffbee | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 182 | 122 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.49e-04 | 183 | 122 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.49e-04 | 183 | 122 | 5 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 184 | 122 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | (1)_T_cells-(1)_T_regulatory|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.53e-04 | 184 | 122 | 5 | 3cbf81757653652441843d85cb7ec1dcf25ca1b0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 185 | 122 | 5 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.56e-04 | 185 | 122 | 5 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 186 | 122 | 5 | d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 186 | 122 | 5 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 1.64e-04 | 187 | 122 | 5 | 457eb3791a8c5458d81833e0701ac5a9bfdee2bf | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 187 | 122 | 5 | 3301e0fca8c436d136c71f1a8fd59b3bb11bdd83 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.64e-04 | 187 | 122 | 5 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 189 | 122 | 5 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 189 | 122 | 5 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-04 | 189 | 122 | 5 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 189 | 122 | 5 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 189 | 122 | 5 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 189 | 122 | 5 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 190 | 122 | 5 | b69709323a9f1b368b5a4f87295b9f7fd9c9be8e | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.81e-04 | 191 | 122 | 5 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.86e-04 | 192 | 122 | 5 | 0b954a4e5857dac45d97c491af9b27cb2d1bd339 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 192 | 122 | 5 | 017f613b1b9c0bd0842e5c1e71d3ac60dd89eadd | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 1.86e-04 | 192 | 122 | 5 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | ILEUM-inflamed-(1)_Tregs|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.86e-04 | 192 | 122 | 5 | 1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 193 | 122 | 5 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | NS-critical-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.90e-04 | 193 | 122 | 5 | 0dd83b21e164147abfd511a927615c40a28781a2 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 193 | 122 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 193 | 122 | 5 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 1.90e-04 | 193 | 122 | 5 | 2ffe44edf2b02d11a7c10513692eb697a10f911e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 193 | 122 | 5 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 193 | 122 | 5 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-04 | 193 | 122 | 5 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-04 | 193 | 122 | 5 | 4fb020f11fd7aff06952bfeaabc79b2c7b8873f6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 193 | 122 | 5 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Severe-Treg|Severe / Disease group and Cell class | 1.95e-04 | 194 | 122 | 5 | 7d232d87262ec5f505901345da5113cabf821321 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-04 | 194 | 122 | 5 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.95e-04 | 194 | 122 | 5 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.00e-04 | 195 | 122 | 5 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | COVID-19-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 2.00e-04 | 195 | 122 | 5 | 9ad844d9d5aac39d133ae8ab9c4839300f08064c | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.00e-04 | 195 | 122 | 5 | 0110b976f98561ecd2e20ff6e7e3960a401bb7c2 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.00e-04 | 195 | 122 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-04 | 195 | 122 | 5 | 050fc59b328391d6e3ce23051764a842dcbb3144 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 195 | 122 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 2.05e-04 | 196 | 122 | 5 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.05e-04 | 196 | 122 | 5 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-04 | 196 | 122 | 5 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 197 | 122 | 5 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | Control-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.09e-04 | 197 | 122 | 5 | b86385c6c1d52ef4e3d855004d77afab61556978 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 197 | 122 | 5 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-04 | 197 | 122 | 5 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.09e-04 | 197 | 122 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-04 | 197 | 122 | 5 | 54fb7197db3c0dc87a1114e1ab1d2bfafd564b35 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 197 | 122 | 5 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|World / disease group, cell group and cell class | 2.09e-04 | 197 | 122 | 5 | 16cf3939e700aef1e16159f0652ba2dfad287e7a | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 197 | 122 | 5 | 59ddd8ff7dddf3747b988374e1a4d80959db803e | |
| Disease | chronic kidney disease, Proteinuria | 9.06e-06 | 11 | 114 | 3 | EFO_0003884, HP_0000093 | |
| Disease | Usher syndrome (is_implicated_in) | 8.83e-05 | 4 | 114 | 2 | DOID:0050439 (is_implicated_in) | |
| Disease | low-density lipoprotein receptor-related protein 1, soluble measurement | 1.47e-04 | 5 | 114 | 2 | EFO_0801772 | |
| Disease | ETS domain-containing protein Elk-3 measurement | 2.20e-04 | 6 | 114 | 2 | EFO_0801588 | |
| Disease | cytochrome c oxidase subunit 6C measurement | 2.20e-04 | 6 | 114 | 2 | EFO_0801515 | |
| Disease | WAP four-disulfide core domain protein 3 measurement | 2.20e-04 | 6 | 114 | 2 | EFO_0802220 | |
| Disease | plastin-2 measurement | 2.20e-04 | 6 | 114 | 2 | EFO_0801885 | |
| Disease | acid ceramidase measurement | 2.20e-04 | 6 | 114 | 2 | EFO_0801339 | |
| Disease | lon protease homolog, mitochondrial measurement | 2.20e-04 | 6 | 114 | 2 | EFO_0801771 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.67e-04 | 80 | 114 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | pulmonary function measurement, forced expiratory volume | 3.97e-04 | 37 | 114 | 3 | EFO_0003892, EFO_0004314 | |
| Disease | aspirin use measurement | 4.64e-04 | 39 | 114 | 3 | EFO_0007013 | |
| Disease | serum non-albumin protein measurement | 5.20e-04 | 361 | 114 | 7 | EFO_0004568 | |
| Disease | cortical surface area measurement | RELN PDE3A ZAN TNRC6B LRRIQ1 PLXDC2 SUOX STAU2 XRN1 AKAP10 FGD6 PLXNA2 SOS1 SOS2 | 6.92e-04 | 1345 | 114 | 14 | EFO_0010736 |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 7.95e-04 | 11 | 114 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | Ciliopathies | 8.90e-04 | 110 | 114 | 4 | C4277690 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.02e-03 | 51 | 114 | 3 | cv:CN043650 | |
| Disease | MAP kinase-activated protein kinase 3 measurement | 1.12e-03 | 13 | 114 | 2 | EFO_0008226 | |
| Disease | cortical thickness | RELN TNRC6B GAS7 USH1C HDGFL3 LRRIQ1 PLXDC2 STAU2 AKAP10 USP15 PLXNA2 SOS2 | 1.26e-03 | 1113 | 114 | 12 | EFO_0004840 |
| Disease | angina pectoris | 1.43e-03 | 125 | 114 | 4 | EFO_0003913 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 1.56e-03 | 59 | 114 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | Congenital total cataract | 1.71e-03 | 16 | 114 | 2 | C0266539 | |
| Disease | rheumatoid arthritis, COVID-19 | 1.97e-03 | 64 | 114 | 3 | EFO_0000685, MONDO_0100096 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 2.42e-03 | 19 | 114 | 2 | C3501846 | |
| Disease | Hydrops Fetalis | 2.42e-03 | 19 | 114 | 2 | C0020305 | |
| Disease | cortical surface area change measurement, age at assessment | 2.42e-03 | 19 | 114 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 2.42e-03 | 19 | 114 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 2.42e-03 | 19 | 114 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 2.42e-03 | 19 | 114 | 2 | C0587248 | |
| Disease | alpha-tocopherol measurement | 2.69e-03 | 20 | 114 | 2 | EFO_0007898 | |
| Disease | Nonsyndromic genetic hearing loss | 3.22e-03 | 76 | 114 | 3 | cv:C5680182 | |
| Disease | LEOPARD Syndrome | 3.25e-03 | 22 | 114 | 2 | C0175704 | |
| Disease | intraocular pressure measurement | 3.68e-03 | 509 | 114 | 7 | EFO_0004695 | |
| Disease | Noonan Syndrome | 3.86e-03 | 24 | 114 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEAEAALQKAWNQGG | 516 | Q9Y6N9 | |
| QLKQNGGLAWSDDAD | 181 | Q8IVW6 | |
| GNWTVNKTEADNIEG | 36 | Q6UW88 | |
| NLTLWTSENQGDEGD | 226 | P31946 | |
| LQGLTNQDLQEGEDW | 241 | Q9HB65 | |
| IQAWEGEDIKNLGNV | 436 | Q15052 | |
| VGKENRQGWAVLQEA | 66 | Q6ZTN6 | |
| VDGWTDLQKQLDNRE | 226 | Q86XQ3 | |
| KVNSQWENGANLDDP | 296 | A4FU28 | |
| ELGEGWGHVKDQQVL | 41 | Q68CJ9 | |
| KWVQGNTDEAQEELA | 621 | O43572 | |
| DIGIWGQLQTDGAKD | 801 | Q8IUA7 | |
| GDKWLDELDSGLQGQ | 66 | Q8TAX9 | |
| KLGGDNTQLEAAEWL | 786 | Q9UDR5 | |
| KGEGLQEGVDWLQDQ | 166 | Q9H0F7 | |
| QWAGIELDEPEGKNN | 311 | Q8N3C7 | |
| QDNGDLLENKHGEFW | 1071 | Q96BY7 | |
| GGRAWEQGQDHDKEN | 246 | Q99618 | |
| TVWLNGKGENDNTLQ | 476 | Q09MP3 | |
| EQLLDCEGEDGWNKL | 136 | P49792 | |
| DGKQIKLQIWDTAGQ | 51 | P61019 | |
| DGKQIKLQIWDTAGQ | 51 | Q8WUD1 | |
| KNGQTVSGLDANWLE | 306 | Q14699 | |
| EQLLDCEGEDGWNKL | 136 | Q99666 | |
| EQLLDCEGEDGWNKL | 136 | O14715 | |
| TIDNTLDQWLQVGGD | 1851 | Q9H1A4 | |
| AGIDEQENWHEGKEN | 106 | P28838 | |
| WGQAGSLDLQIDEEQ | 41 | Q96JQ0 | |
| TLLEQWEKEHGSGQD | 16 | Q9Y4B6 | |
| GEKNSVDWGDLNLVL | 2131 | Q14667 | |
| DWGDSIEVKNEDQIQ | 81 | Q6UB28 | |
| EGQEGAWEAQALVLK | 86 | P59942 | |
| NKDVGIWLKGEDQSE | 331 | Q8NC56 | |
| QEELSGKGQEADQLW | 456 | Q9BQS8 | |
| GVQEAGWDLDDNNDK | 526 | Q9UN88 | |
| SLEFLGNGNELEWED | 106 | Q86WG3 | |
| AGTEEIKNEINGNWI | 31 | Q53EL6 | |
| GGGQKVNDDIIVNWV | 511 | P13796 | |
| QGEGNLELNWLLGKD | 376 | O75051 | |
| EGLVEGGENIKQANW | 56 | P17858 | |
| NGKVNDDVGIDWTNE | 921 | Q14432 | |
| NWGALNQSKQGESEK | 71 | Q96JB1 | |
| QENQEDLGLWEEKFG | 186 | Q8TET4 | |
| ELEELNLSWNSKVGG | 171 | Q6UY01 | |
| LGDVEKGDNQNDSWI | 101 | P32455 | |
| LGDIEKGDNENDSWI | 101 | P32456 | |
| LGDVKKGDNQNDSWI | 101 | Q9H0R5 | |
| DINSFDQWGVELGKQ | 506 | P06744 | |
| GGNWDNISDGAKDLL | 646 | Q9UK32 | |
| ELGNDWDSATKQLLG | 1691 | Q9UKK3 | |
| IDEDGNNQWPEGLKF | 121 | O00410 | |
| NKRKGFNEGLWEIEN | 76 | Q9Y3E1 | |
| FNEGLWEIENNPGVK | 81 | Q9Y3E1 | |
| EIEENPKDNAWNSGI | 641 | Q96JM4 | |
| AEEIKQGNDNGVLEW | 181 | Q8TCQ1 | |
| DGLDQNDWAIDNVLI | 2646 | P78509 | |
| QALGLGEDWNVEKGT | 56 | Q02809 | |
| NGDKWEAEIAANIQA | 191 | O00217 | |
| NQDGWDGKQENEERL | 456 | Q92794 | |
| LNVWLGIKNEDADEN | 326 | Q92569 | |
| EQLLDCEGEDGWNKL | 136 | A6NKT7 | |
| QVKNDLSGGVLNDWS | 261 | Q92838 | |
| GEAIANENWDLKEEI | 86 | Q9UBT7 | |
| DSTGQQVWQDLLQDG | 356 | Q9HCG7 | |
| EILWQHNDKNIGGDE | 56 | P07766 | |
| GWLDQEDQEAPLQKG | 666 | Q8IWC1 | |
| ILNKENQDDDGFWEG | 596 | O94868 | |
| NQEEQEVETDWGLLK | 236 | Q9Y6Q1 | |
| DILEQVGESGWFQKQ | 6 | O15245 | |
| GKWQQQGDLQDTKEN | 481 | P05060 | |
| KSGQDQLDSQQEGWV | 541 | Q9UPN4 | |
| IENGDGISEPDWQIK | 756 | Q56UN5 | |
| FVRGWLKGQQEDKQD | 1761 | Q9HC10 | |
| QLGVPVNDKDDAGWS | 61 | O75832 | |
| QDQIAVGEDGFKQWD | 41 | Q9NPI5 | |
| EGKAWGNQTIQADEK | 4196 | O75445 | |
| EQLLDCEGEDGWNKL | 136 | Q7Z3J3 | |
| GEVGDWKNLFSEIQN | 261 | Q6IMI4 | |
| NEIQKNIDGWEGKDI | 421 | Q07890 | |
| VEIKGDDQLSGAQQW | 411 | Q92733 | |
| QVQGKEWLELEEDAQ | 91 | Q9ULQ0 | |
| KAAEQGWVDGQLQLG | 476 | Q9UBV2 | |
| EDEQGDENKARGNWS | 181 | Q9Y345 | |
| GIKNDDKNILTTWGD | 371 | Q5JRA6 | |
| QEEGSLGEAWAQVKK | 266 | O60861 | |
| IQRGIWDGDAKAVQQ | 6 | Q9NQV8 | |
| QWKDDLAEEDQQAGE | 66 | Q8TDN2 | |
| EQNGKQKWREEGEAG | 56 | Q7Z5D8 | |
| QFADGKPGDQILDWQ | 26 | Q6UX71 | |
| GGIDNDIKVWDLRQN | 211 | Q96DI7 | |
| QKNIDGWEGKDIGQC | 426 | Q07889 | |
| GKPELWSQDEVEQAG | 1376 | Q7RTU9 | |
| GALWGELQDNSQKKV | 2766 | Q9NRC6 | |
| EGEKEFDQNVKLWGV | 271 | Q9UHD1 | |
| GFNEGLWEIDNNPKV | 76 | O75475 | |
| KLVVWEAAQNGADEG | 211 | Q5T6F2 | |
| EWQNKSEFEGQQGLK | 121 | Q8NDQ6 | |
| GGKEDLIWELLNQAQ | 276 | P02787 | |
| WDLENGKQIKSIDAG | 91 | Q9GZS3 | |
| GNKASVWEELIENGK | 506 | Q99973 | |
| KPENLLVWDGAAGEQ | 1721 | Q15772 | |
| LQDQLEKTGENKGWS | 381 | Q9NUL3 | |
| SNQEGWKKESQQDNG | 91 | P49675 | |
| QNEDIEAICLGQGWA | 531 | O75717 | |
| EQKGIESDWQGLLVG | 666 | Q6ZV73 | |
| WPGENENGAEKVQEI | 1016 | Q8IZH2 | |
| TQNNAEIWNGSGKEA | 1201 | Q6P2S7 | |
| GQVLVIEQKNEDGTW | 206 | Q9Y4E8 | |
| NGSWDLNEDLAKILG | 691 | O00534 | |
| QGKELWQEGREFLQD | 61 | A8MWA4 | |
| SKQDRENEEGDTGNW | 791 | Q9UPT8 | |
| DKNVQEPEQGEAWKS | 451 | Q9BRR0 | |
| GNWKHEGQVEDLQEN | 16 | Q9Y2P0 | |
| REQQQWGLEDEKIAG | 326 | Q63HK3 | |
| TWEGIQAGKELEEQH | 146 | P37837 | |
| GGLTWQVAKLDGEEQ | 466 | P51687 | |
| NVQNAEGTKWGEEAL | 646 | Q8NAP3 | |
| NADEVIWLLGDGQAQ | 401 | Q96PF1 | |
| GEQIEVFANKLGEQW | 571 | Q96FV9 | |
| KNGWGEEVDQTKNSN | 746 | Q9UPQ9 | |
| HENNEDDGVLGWNIQ | 171 | Q8NC26 | |
| GDKEELGNSWQTDQD | 1311 | Q9Y493 | |
| AIWNGGQDIVADPKD | 336 | Q5VXJ0 | |
| ADGLWNQKILFEEQD | 466 | P59046 | |
| GTNALVEWQAPKDDG | 946 | Q14324 |